about
Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyUltrasensitive detection of 3D cerebral microvascular network dynamics in vivoCyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy studyHOIL-1L functions as the PKCĪ¶ ubiquitin ligase to promote lung tumor growthThe orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model.Glioblastoma extracellular vesicles: reservoirs of potential biomarkers.Overexpression of vascular endothelial growth factor indicates poor outcomes of glioma: a systematic review and meta-analysis.MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cellsTalin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme.High expression of VEGF and PI3K in glioma stem cells provides new criteria for the grading of gliomas.Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastomaTranscriptional signaling pathways inversely regulated in Alzheimer's disease and glioblastoma multiform.Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor.Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies.Canine brain tumours: a model for the human disease?Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma.CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma.Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomideFerritin heavy chain as a molecular imaging reporter gene in glioma xenografts.C-type natriuretic peptide-modified lipid vesicles: fabrication and use for the treatment of brain glioma.Bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis of randomized controlled trials.The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cellsCombined treatment of fasudil and glutamate decreased the viability of human glioblastoma cells by excitotoxicity through NMDAR in vitroAutophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis.Hyalomma dromedarii (Acari: Ixodidae) Salivary Gland Extract Inhibits Angiogenesis and Exhibits In Vitro Antitumor Effects.Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression.Overexpression of COX7A2 is associated with a good prognosis in patients with glioma.Differentiating enhancing multiple sclerosis lesions, glioblastoma, and lymphoma with dynamic texture parameters analysis (DTPA): A feasibility study.Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging.MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.Autophagy activation promotes bevacizumab resistance in glioblastoma by suppressing Akt/mTOR signaling pathway.The roles of TRIO and F-actin-binding protein in glioblastoma cells.
P2860
Q26998111-D68F09D2-DAD6-42B8-99C4-37DBE9B6FE74Q27307630-4AEFA91C-84A1-4CB9-933A-7D4D7A040F3AQ33829590-BFE2B3BB-35F9-4E86-A925-9EFB98A2F281Q34425893-ADFB0F87-7F83-430C-8B2E-D8352B6C34EDQ34968805-8E4D226A-D3F4-4367-8F03-BFA8E3E31EC7Q35122209-74DBB4A8-CE26-4FA7-92AE-CAEA1BF0D167Q35756369-284DDCB7-CBCF-46BA-AD9A-89E8057601F2Q35832262-905E2A5A-CD47-4A99-9A7E-E041C28FEC3CQ35986799-648D16B3-75D1-456F-A8E8-882DB13960B8Q36413742-7269C8A8-63B4-4ADD-A742-995ECAFE8664Q36524261-C5CB20CF-D13D-4E87-96D3-D6BC74F375D1Q36575238-6802A0A2-50B9-4E2D-900C-18DE85AA856FQ36972492-CBC42865-0BA0-463B-94C4-7F4419C6CC29Q37606600-3F6F8056-36B5-4872-A968-9F725CE25064Q37688411-008DF0F6-955E-4BA9-B6C2-168BC1FD1329Q38255001-746AAF62-ED9F-4DE4-BAD4-934EA16B9640Q38491009-B3CDF191-9FAE-4C3B-8667-055D04F4DEFFQ38635290-87BC29E1-37E8-464B-82C4-6404B50E4394Q38683271-AB8CE6B2-A9A4-44C3-8280-B18F0DB50EACQ38703584-7F765F02-6761-49C3-BAE3-BF8B9C40438DQ38769439-E94B06EE-C933-411F-B4A1-20B3D04850F0Q38885201-3ADC5C98-F178-4B85-B4DC-B311FEEAF5A7Q38902268-3FB08B74-96B4-49F1-A38E-9588AEE30A0EQ40313711-9C6E2A4A-FD64-411F-A285-3E2F15A4AEDAQ41093388-39A32B83-35CF-4695-9517-0D51AEE358E1Q41342037-5F011F5A-82D7-4246-A78C-14102C03F685Q41364759-1D4E2D22-8AA1-4201-836A-242DE3E01424Q41571486-CD860086-C8D6-4489-8AB5-E34DD4FE2305Q41912135-56D17478-046C-4D88-80CE-813CB0ABA737Q42315822-C37DDB59-95A8-4E0C-AEB8-F93CD8D1D824Q46601312-3FFBA2FD-3641-4051-9433-BAF885AB9D96Q46878604-9BB67839-6200-4547-A802-26EB36BF2A26Q47126472-5C66FE27-BE28-40C0-9526-94695DCE9149Q47729454-2E219389-DD97-45ED-97A1-EE41CFF19B40Q47830783-ECA39A66-B376-4987-81E3-6547CF04B5EBQ47925570-8A38ED7D-47D9-403E-A741-CAF020A13713Q48246862-59A6CA95-A010-48A4-AFC9-B932C9EACB29Q48837549-9DB5FF19-0193-48E9-AB8C-1F451EB87FA3Q49533311-BC9AB0A2-6EBF-4316-B909-E75CE7D4EBB3Q49831463-AE357D49-91B9-43B6-BEDA-800AC5E7523A
P2860
description
2013 nĆ® lÅ«n-bĆ»n
@nan
2013幓ć®č«ę
@ja
2013幓č«ę
@yue
2013幓č«ę
@zh-hant
2013幓č«ę
@zh-hk
2013幓č«ę
@zh-mo
2013幓č«ę
@zh-tw
2013幓č®ŗę
@wuu
2013幓č®ŗę
@zh
2013幓č®ŗę
@zh-cn
name
Angiogenesis in glioblastoma
@en
Angiogenesis in glioblastoma
@nl
type
label
Angiogenesis in glioblastoma
@en
Angiogenesis in glioblastoma
@nl
prefLabel
Angiogenesis in glioblastoma
@en
Angiogenesis in glioblastoma
@nl
P2860
P356
P1476
Angiogenesis in glioblastoma
@en
P2093
Philip A Marsden
P2860
P304
P356
10.1056/NEJMCIBR1309402
P407
P577
2013-10-01T00:00:00Z